UK Scientists To Grow Miniature Human Organs For Drug Testing
An anonymous reader quotes a report from The Guardian: Miniature human organs and other tissues are to be grown from NHS patients' cells in a drive to improve medicine testing and reduce the number of animals used in drug development. Scientists will use the clumps of tissue to learn how diseases vary between patients, helping them identify which treatments are best for different people based on…
The Guardian reports that scientists in the UK will be cultivating miniature human organs and tissues from NHS patient cells in an effort to enhance drug testing methods and decrease the reliance on animal models. The objective is to gain a deeper understanding of how diseases differ among individuals, enabling researchers to determine the most suitable treatment for specific conditions based on the unique pathology involved.
This shift away from traditional animal models signifies a move towards more accurate and reliable tests grounded in human tissues. Scientists have been growing tiny organoid clumps derived from human organs for over a decade, and studies have shown that these miniaturized structures can replicate crucial aspects of complete organs and tissues, including their dysfunction due to disease and drug responses.
By utilizing organoids developed from diseased human tissues, researchers can assess whether novel drug candidates can rectify pathological alterations in certain patients or swiftly identify ineffective drugs during early stages of development. Historically, more than 90% of drugs successfully passing animal testing ultimately fail in human trials, casting doubt on the efficacy of these tests.
Both US and European medical authorities now advocate for alternative approaches whenever feasible. Matthias Zilbauer, a clinical professor of paediatric gastroenterology at the Cambridge Stem Cell Institute, expressed that the initiative is anticipated to significantly reduce animal usage and alter the approach to drug development.
While certain issues persist that cannot be addressed using these new models, a substantial reduction in animal testing is projected. Zilbauer emphasized that numerous human diseases either do not manifest in animals or exhibit different patterns due to their non-human nature. He stressed the importance of tests and models capable of predicting which treatments prove effective for specific patient groups, highlighting that mice are incapable of providing such insights.
Written by urgent.news from Slashdot's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.